
|Articles|September 1, 2006
Novel occlusive patch improves responses to topical psoriasis medications
Interim results from an open-label controlled clinical study indicate that occlusion with a specially designed hydrogel patch safely and significantly enhances the efficacy of a variety of topical medications that are used in the treatment of psoriasis, reported researchers from the University of California at the American Academy of Dermatology's Summer Academy '06.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
3
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
4
Introducing Dermatology Times NP/PA Connect
5











